| Structure |
Chemical Name |
CAS |
MF |
 |
Bisoprolol Impurity 51 |
|
|
 |
2-Deoxy-2,2-difluoro-D-ribofuranose-3,5-dibenzoate-1-methanesulfonate |
134877-42-2 |
C20H18F2O8S |
|
|
Pitavastatin Impurity 105 |
|
|
|
|
Nirmatrelvir Impurity 11 |
|
|
|
|
Bumetanide Impurity 21 |
|
|
![4'-(Hydroxymethyl)-[1,1'-Biphenyl]-2-Carboxylic Acid](/CAS/GIF/158144-54-8.gif) |
4'-(Hydroxymethyl)-[1,1'-Biphenyl]-2-Carboxylic Acid |
158144-54-8 |
C14H12O3 |
|
|
Brivaracetam Impurity 118 |
|
|
|
|
1-(4-((2-(4-hydroxypiperidin-1-yl)ethyl)(methyl)carbamoyl)benzyl)piperidine-4-carboxylic acid |
2975124-11-7 |
|
|
|
Empagliflozin Impurity 108 |
|
|
|
|
Perospirone Impurity 28 |
|
|
|
|
Perospirone Impurity 23 |
|
|
|
|
Perospirone Impurity 16 |
|
|
|
|
Dolutegravir Impurity 24 |
|
|
|
|
Paxlovid Impurity 18 |
|
|
|
|
Related impurities of fluoxetine sodium 8 |
|
|
|
|
Fondaparinux sodium impurity 15 |
|
|
|
|
Fondaparinux Sodium Impurity 10 |
|
|
|
|
Oxacillin sodium Impurity E |
|
|
|
|
Revefenacin Impurity 19 |
|
|
|
|
Caspofungin Impurity 11 |
|
|
|
|
Miglitol Isomer ImpurityA |
|
|
|
|
sodium (6R,7S)-7-(2-mercaptoacetamido)-7-methoxy-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate |
|
|
|
|
Olodaterol Impurity 33 |
|
|
 |
ダソトラリン塩酸塩 |
675126-08-6 |
C16H15Cl2N.ClH |
 |
3-(4-ホルミルアミノブチリル)ピリジン |
887355-56-8 |
C10H12N2O2 |
 |
Didesmethyl Erlotinib Hydrochloride Salt |
183320-12-9 |
C20H20ClN3O4 |
 |
Lisinopril R,S,S-Diketopiperazine |
219677-82-4 |
C21H29N3O4 |
 |
N-(3-(4-(3-ピリジル)ピリミジン-2-イルアミノ)-4-メチルフェニル)-4-クロロメチルベンズアミド |
404844-11-7 |
C24H20ClN5O |
 |
6-Mercaptopurine disulfide |
49808-20-0 |
C10H6N8S2 |
 |
デキシバカイン |
24358-84-7 |
C15H22N2O |
 |
5-ForMyl-8-hydroxycarbostyril |
68304-21-2 |
C10H7NO3 |
|
|
Capecitabine Related Compound A |
|
|
 |
1-Pyrrolidineaceticacid,2-(aminocarbonyl)-,(2S)-(9CI) |
277751-02-7 |
C7H12N2O3 |
 |
2-Pyrrolidinecarbonitrile,1-acetyl-,(2S)-(9CI) |
700376-84-7 |
C7H10N2O |
 |
4-メチルピペラジン-1-カルボン酸エチル |
59325-11-0 |
C8H16N2O2 |
 |
(1S,4R)-4-Amino-2-cyclopenten-1-carboxylic Acid Hydrochloride |
134234-04-1 |
C6H9NO2 |
 |
(3R)-3α,5α,7β,9β,11α,13β-ヘキサメチル-4β,6β,7,12β-テトラヒドロキシ-14β-エチル-1-オキサシクロテトラデカン-2,10-ジオン |
3225-82-9 |
C21H38O7 |
![2,5-ジアザテトラシクロ[13.4.0.02,7.08,13]ノナデカ-1(19),8,10,12,15,17-ヘキサエン](/CAS/GIF/71936-92-0.gif) |
2,5-ジアザテトラシクロ[13.4.0.02,7.08,13]ノナデカ-1(19),8,10,12,15,17-ヘキサエン |
71936-92-0 |
C17H18N2 |
![(S)-1-メトキシ-2-メチルオキシ-3-ヒドロキシ-7-アセチルアミノ-10-メチルチオ-6,7-ジヒドロベンゾ[a]ヘプタレン-9(5H)-オン](/CAS/GIF/87424-25-7.gif) |
(S)-1-メトキシ-2-メチルオキシ-3-ヒドロキシ-7-アセチルアミノ-10-メチルチオ-6,7-ジヒドロベンゾ[a]ヘプタレン-9(5H)-オン |
87424-25-7 |
C21H23NO5S |
 |
2,6-di-tert-butyl-4-methylene-2,5-cyclohexadienone |
2607-52-5 |
C15H22O |
 |
(4S)-2-アセチル-3,5β,6α,10,12,12aβ-ヘキサヒドロキシ-4β-(ジメチルアミノ)-6-メチル-1,4,4aβ,5,5aβ,6,11,12a-オクタヒドロナフタセン-1,11-ジオン |
6542-44-5 |
C23H25NO8 |
 |
6,8,11-トリヒドロキシ-1-メトキシ-5,12-ナフタセンジオン(DOXORUBICIN IMPURITY) |
64845-67-6 |
C19H12O6 |
|
|
Nicorandil Impurity 1 |
|
|
|
|
Posaconazole Impurity 32 |
|
|
|
|
Posaconazole Impurity 61 |
|
|
|
|
Linagliptin Impurity 40 |
|
|
 |
Minocycline N-Hydroxymethyl Impurity |
1075240-33-3 |
C24H29N3O8 |
 |
Mivacurium Chloride Impurity 3 |
740777-60-0 |
C33H46NO9+ |
 |
Mupirocin EP Impurity E |
71087-96-2 |
C26H44O9 |
|
|
Nifuratel Impurity 7 |
|
|
 |
Norepinephrine EP Impurity D |
1932110-67-2 |
C9H13NO3 |
|
|
Olaparib Impurity 4 |
|
|
|
|
Paclitaxel EP Impurity M |
|
|
 |
Parecoxib Sodium Impurity H |
501093-49-8 |
C16H14N2O4S |
 |
(S)-4-(4-Nitrobenzyl)-2-oxazolidinone |
139264-55-4 |
C10H10N2O4 |
 |
2-(4-Hydroxymethylphenyl)phenylsulfonamide |
158144-55-9 |
C15H14O3 |
![4-[2-(シクロプロピルメトキシ)エチル]フェノール](/CAS/GIF/63659-16-5.gif) |
4-[2-(シクロプロピルメトキシ)エチル]フェノール |
63659-16-5 |
C12H16O2 |
 |
2-(2-クロロエチル)チオフェン |
19995-38-1 |
C6H7ClS |
 |
N-Methyl Pantoprazole, mixture of 1 and 3 isomers |
624742-53-6 |
C17H17F2N3O4S |
 |
rel-(αR*,α'S*)-1-メチル-α,α'-ジフェニル-2α*,6α*-ピペリジンジエタノール |
552-72-7 |
C22H29NO2 |
 |
4-Amino-1-3,5-di-O-benzoyl-2-deoxy-2,2-difluoro-a-D-erythro-pentofuranosyl)-2(1H)-pyrimidinone |
134790-40-2 |
C23H19F2N3O6 |
 |
9'-DESMETHYL GRANISETRON (グラニセトロン不純物C) |
160177-67-3 |
C17H22N4O |
![3-[4-[エチル]フェノキシ]-1-(イソプロピルアミノ)-2-プロパノール](/CAS/20200119/GIF/67193-95-7.gif) |
3-[4-[エチル]フェノキシ]-1-(イソプロピルアミノ)-2-プロパノール |
67193-95-7 |
C14H23NO2 |
 |
3,5-ビス(ベンジルオキシ)安息香酸ベンジル |
50513-72-9 |
C28H24O4 |
![[(2,3-ジヒドロ-1,5-ジメチル-3-オキソ-2-フェニル-1H-ピラゾール-4-イル)アミノ]メタンスルホン酸](/CAS/GIF/117-38-4.gif) |
[(2,3-ジヒドロ-1,5-ジメチル-3-オキソ-2-フェニル-1H-ピラゾール-4-イル)アミノ]メタンスルホン酸 |
117-38-4 |
C12H15N3O4S |
 |
4-メチルけい皮酸エチル |
24393-49-5 |
C12H14O2 |
 |
3-(2-ヒドロキシエチル)アミノプロピオニトリル |
33759-44-3 |
C5H10N2O |
 |
2-アミノ-5-ブロモベンズアルデヒド |
29124-57-0 |
C7H6BrNO |
 |
(R)-1-(2-チエニル)-3-(メチルアミノ)-1-プロパノール |
116539-57-2 |
C8H13NOS |
 |
3-OXO-3,4-DIHYDROPYRAZINE-2-CARBONITRILE |
81411-78-1 |
C5H3N3O |
 |
RP 48497 (Eszopiclone Impurity C) |
148891-53-6 |
C11H7ClN4O |
 |
3-(1-methyl-1H-indole-3-carbonyl)hexanedioic acid |
1352491-75-8 |
C16H17NO5 |
 |
デクラジノースロキシスロマイシン (ROXITHROMロキシトロマイシン不純物B |
214902-82-6 |
C33H62N2O12 |
 |
Unii-o0p4I5851i |
139563-29-4 |
C28H37ClN4O2S |
 |
デヒドロモナコリンK |
109273-98-5 |
C24H34O4 |
![(3S)-3-[3-[(1E)-2-(7-クロロ-2-キノリニル)エテニル]フェニル]-4,5-ジヒドロ-2-ベンゾキセピン-1(3H)-オン](/CAS2/GIF/1100617-38-6.gif) |
(3S)-3-[3-[(1E)-2-(7-クロロ-2-キノリニル)エテニル]フェニル]-4,5-ジヒドロ-2-ベンゾキセピン-1(3H)-オン |
1100617-38-6 |
C27H20ClNO2 |
 |
O-Desethyl N-Trityl Candesartan Cilexetil |
934495-65-5 |
C50H44N6O6 |
 |
N-(Ethylamino) Fluvoxamine
|
1217262-11-7 |
C17H26F3N3O2 |
 |
ISO RIBAVIRIN (リバビリン不純物G) |
39030-43-8 |
C8H12N4O5 |
 |
(R)-(+)-トルバプタン |
331947-66-1 |
C26H25ClN2O3 |
 |
(E)-セフジニル |
178601-88-2 |
C14H13N5O5S2 |
|
|
Flucloxacillin impurity E |
|
|
 |
4-(4-Piperidyl)-1-butanol |
57614-92-3 |
C9H19NO |
 |
Pitavastatin Methyl Ester |
849811-78-5 |
C26H26FNO4 |
 |
6,8-ジメトキシモキシフロキサシン |
1029364-73-5 |
C22H27N3O5 |
 |
3'-O-(5'-Deoxy-α-D-ribofuranosyl) Capecitabine |
1262133-64-1 |
C20H30FN3O9 |
 |
5-Chlorodescyano CitalopraM Oxalate |
64169-46-6 |
C21H23ClFNO5 |
 |
N-メチル-L-バリン酸アシクロビル塩酸塩 |
1346617-39-7 |
C14H23ClN6O4 |
 |
rac N,N-DidesMethyl-N-(4-hydroxyphenethyl)-O-desMethyl Venlafaxine |
1346601-21-5 |
C22H29NO3 |
 |
rac-11-Deoxy-8(12)-dehydro Misoprostol |
1331639-92-9 |
C22H36O4 |
 |
5-Nitro-1H-iMidazole-1-ethanol |
5006-68-8 |
C5H7N3O3 |
|
|
Iohexol related Compound I |
|
|
![2,2'-Methylene Bis[Ranitidine]](/CAS/GIF/207592-21-0.gif) |
2,2'-Methylene Bis[Ranitidine] |
207592-21-0 |
C27H44N8O6S2 |
 |
炭酸クロロメチルプロピル |
35273-90-6 |
C5H9ClO3 |
 |
2-AMino-5-(trifluoroMethoxy)phenyl Thiocyanate |
1391054-04-8 |
C8H5F3N2OS |
 |
Bisacodyl Related Compound B (20 mg) (2,4'-(Pyridin-2-ylmethylene)diphenol) |
16985-05-0 |
C18H15NO2 |
![Doxepin Related Compound C (25 mg) ((E-3-(dibenzo[b,e]oxepin-11(6H)-ylidene)-N-methylpropan-1-amine hydrochloride)](/CAS/20211123/GIF/4504-96-5.gif) |
Doxepin Related Compound C (25 mg) ((E-3-(dibenzo[b,e]oxepin-11(6H)-ylidene)-N-methylpropan-1-amine hydrochloride) |
4504-96-5 |
C18H20ClNO |
![Ioversol Related Compound B (50 mg) (N,N'-bis(2,3-dihydroxypropyl)-5-[(N-(2-hydroxyethyl)-carbamoyl)methoxy]-2,4,6-triiodoisophthalamide)](/CAS/20180808/GIF/104517-96-6.gif) |
Ioversol Related Compound B (50 mg) (N,N'-bis(2,3-dihydroxypropyl)-5-[(N-(2-hydroxyethyl)-carbamoyl)methoxy]-2,4,6-triiodoisophthalamide) |
104517-96-6 |
C18H24I3N3O9 |
 |
Edoxaban Impurity 12 (1R,2R,4S) |
500572-10-1 |
C24H30ClN7O4S |
 |
メシル酸パロキセチン |
217797-14-3 |
C20H24FNO6S |